Alimentary TractImpact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients
Introduction
Coeliac disease (CD) is an autoimmune enteropathy that develops in genetically predisposed subjects and is triggered by ingestion of gluten, found in wheat, and of related prolamines, found in barley and rye [1]. The histological hallmark of the disease is villous atrophy. Clinical manifestations are heterogeneous and largely related to intestinal malabsorption that, in most cases, results in selective deficiency of dietary components such as iron, vitamins, calcium or cholesterol, and in a minority of cases results in a classical malabsorption syndrome. Due to the disease characteristics the majority of CD patients has been reported to have normal or low BMI in population based [2] and outpatient based studies [3], [4], [5]. Furthermore, when compared to controls cholesterolemia has been reported to be lower in undetected celiacs in the general population [6] and in selected coeliac patients referred to a CD clinic [7], [8]. These latter observations suggest not only that untreated CD patients may have a favourable cardiovascular (CV) risk profile, but also that CD may confer protection from ischaemic heart disease [6], [8]. However, results from epidemiological studies are rather contradictory on this point [9], [10], [11], [12], [13], [14], [15].
The only treatment for CD is lifelong adherence to a gluten-free diet (GFD) [1], [16], which is expected to result in reconstitution of the small intestinal villous structure, symptoms disappearance and improvement of nutritional status and general well being. Most of the emphasis on GFD focuses on strict avoidance of gluten [1], [16], [17], but available information suggests that this diet may not be nutritionally adequate because it is rich in simple carbohydrates [18], [19] and saturated fatty acids [20] and poor in fibres, micronutrients, vitamins and complex carbohydrates [18], [19], [21], [22], [23].
Taken together the observations reported above have raised concerns that GFD may alter the favourable CV risk profile of untreated CD patients, and thus the concept of active identification and treatment of asymptomatic undiagnosed coeliac patients has been questioned [24]. Available evidence is scarce, limited to the assessment of a single risk factor [2], [5], [8], [24], [25], [26] and, with few exceptions [3], [4], mostly based on small numbers of patients. In some studies, the BMI has been reported to increase during GFD [3], [27], especially in underweight patients [4], and to be higher in treated CD patients than in untreated patients [27]. Other studies assessing changes in lipid profile and homocysteine levels, reported increased high-density lipoprotein (HDL) cholesterol levels [8], [24], [27], with increased [24], [27] or unchanged [8] total cholesterol, and decreased homocysteine levels [5], [25], [26]. These results do not provide clear-cut evidence on whether GFD determines a better or a worse CV risk profile in CD patients.
The aim of our retrospective study was to assess changes in multiple factors associated with CV risk in a large cohort of CD patients studied before and during GFD.
Section snippets
Materials and methods
Clinical, serological and histological data, collected before and during GFD, were retrospectively collected from a prospectively maintained database of all CD patients referred to our CD Clinic from January 1990 to July 2011. CD was diagnosed on the basis of typical duodenal histopathology and positive CD-related serology, either tissue transglutaminase (tTG) or anti-endomysial antibodies (EMA). The information extracted from the database included: demographic characteristics, CD-related
Statistical methods
Continuous variables are expressed as means ± standard deviation (SD) and categorical variables are expressed as frequencies and proportions. Differences between results obtained before and during GFD were tested for statistical significance using the t-test for paired observations of continuous variables, and the χ2-test or Fisher's exact test for categorical variables, as appropriate. Statistical analysis was performed using SAS® 9.2 (Cary, NC, USA) and GraphPad Prism® 5.0 (La Jolla, CA, USA)
Patients’ characteristics
Of the 1740 CD patients recorded in our CD database, 923 had laboratory tests available both at baseline and between 1 and 5 years during GFD, of which 759 had no associated disease and 715 were older than 15 years of age, thus fulfilling our inclusion criteria. Anthropometric, clinical and histological characteristics of patients at time of CD diagnosis are detailed in Table 1. Mean age at diagnosis was 35 ± 13 years and 70.5% were female. In 82% the reason for first referral was presence of
Discussion
Our study shows that at baseline the majority of CD patients were in the low-risk category for CV risk, and that GFD significantly alters these factors causing one third of patients to switch to different CV risk categories.
When considering BMI, 17% of our patients was underweight and 14% overweight/obese at baseline. This distribution is remarkably similar to previous reports [2], [4], although a lower prevalence of underweight patients [3], [9] and a higher prevalence of overweight patients
Conflict of interest statement
None declared.
Acknowledgments
We are grateful to Nurse Elvira Spreafichi and to Mrs Anna Tomasini for their assistance in our clinical practice.
References (41)
- et al.
Coeliac disease
Lancet
(2009) - et al.
Low plasma cholesterol: a correlate of nondiagnosed coeliac disease in adults with hypochromic anemia
American Journal of Gastroenterology
(1999) - et al.
Death from ischaemic heart-disease and malignancy in adult patients with coeliac disease
Lancet
(1976) - et al.
American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Coeliac Disease
Gastroenterology
(2006) - et al.
Body composition and dietary intakes in adult coeliac disease patients consuming a strict gluten-free diet
American Journal of Clinical Nutrition
(2000) - et al.
Change in lipid profile in coeliac disease: beneficial effect of gluten-free diet
American Journal of Medicine
(2006) - et al.
Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics
Clinical Gastroenterology and Hepatology
(2005) Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘coeliac sprue’)
Gastroenterology
(1992)- et al.
Five year time course of coeliac disease serology during gluten free diet: results of a community based “CD-Watch” program
Digestive and Liver Disease
(2010) - et al.
The metabolic syndrome
Lancet
(2005)
Coeliac disease and body mass index: a study of two Swedish general population-based registers
Scandinavian Journal of Gastroenterology
Overweight in coeliac disease: prevalence, clinical characteristics, and effect of a gluten-free diet
American Journal of Gastroenterology
Body mass index in coeliac disease: beneficial effect of a gluten-free diet
Journal of Clinical Gastroenterology
Homocysteine and related B-vitamin status in coeliac disease: effects of gluten exclusion and histological recovery
Scandinavian Journal of Gastroenterology
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England
Gut
Cholesterol profile in people with newly diagnosed coeliac disease: a comparison with the general population and changes following treatment
British Journal of Nutrition
Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study
Alimentary Pharmacology and Therapeutics
Malignancy and mortality in a population-based cohort of patients with coeliac disease or “gluten sensitivity”
World Journal of Gastroenterology
No difference in mortality in undetected coeliac disease compared with the general population: a UK cohort study
Alimentary Pharmacology and Therapeutics
Small-intestinal histopathology and mortality risk in coeliac disease
Journal of the American Medical Association
Cited by (41)
Nutrition Assessment, Interventions, and Monitoring for Patients with Celiac Disease: An Evidence Analysis Center Scoping Review
2020, Journal of the Academy of Nutrition and DieteticsCitation Excerpt :These studies assessed various outcomes, including adherence/management,35,38 gastrointestinal symptoms and conditions,35,36 immunology/serology measures,35,39 mental/cognitive health,35,37 and quality of life (Figure 4).35,37,39 Eight systematic review/meta-analysis,42-49 9 experimental trials,50-58 and 176 observational studies59-234 examined the effects of gluten-free diet. Most of the systematic reviews/meta-analyses44-49 were published between 201544,45 and 2018.48,49
Trending Cardiovascular Nutrition Controversies
2017, Journal of the American College of CardiologyCitation Excerpt :Although avoiding gluten is essential for patients with GRDs, it is critically important that patients consume a nutritionally adequate diet that meets energy needs. There is limited information about the effects of a gluten-free diet on CV risk factors in patients with CD, but there is no evidence for CV outcomes benefit of this dietary pattern (146). For patients with GRDs, a gluten-free diet that is rich in fruits and vegetables, legumes and dried beans, lean protein sources, nuts and seeds, low-fat dairy or nondairy alternatives rich in calcium and vitamin D, and healthy fats, including omega-3 fatty acids, plays an important role in management of symptoms.
Clinical guidelines on the diagnosis and treatment of celiac disease in Mexico
2018, Revista de Gastroenterologia de MexicoNon-coeliac gluten or wheat sensitivity: Emerging disease or misdiagnosis?
2017, Medical Journal of AustraliaCitation Excerpt :The diet also differs in regards to protein55 and fat54,56 content, although accounts vary in regards to the specific breakdown. A gluten-free diet may adversely affect cardiovascular risk factors such as total cholesterol levels,57 weight gain leading to obesity,57 glucose tolerance57 and blood pressure58 and may lead to development of the metabolic syndrome.58 A potential explanation for this is the higher glycaemic load of gluten-free foods.54,59
Guidelines for best practices in monitoring established coeliac disease in adult patients
2024, Nature Reviews Gastroenterology and Hepatology